RecruitingNCT06401889

Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy


Sponsor

Mayo Clinic

Enrollment

25 participants

Start Date

Jul 19, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study evaluates changes in skin quality and self-esteem among breast cancer patients who are initiating aromatase inhibitor therapy.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating whether a skincare routine can help improve skin appearance and quality of life in postmenopausal breast cancer survivors who are taking aromatase inhibitor medications (hormone-blocking drugs that can cause skin dryness and aging as a side effect). **You may be eligible if...** - You are a woman aged 18 or older - You are postmenopausal and your doctor has recommended an aromatase inhibitor for your breast cancer - You have hormone receptor-positive breast cancer at stage 0–III - You have not received prior chemotherapy or hormone therapy for this breast cancer - You are willing to avoid facial procedures (fillers, lasers, Botox, etc.) during the study **You may NOT be eligible if...** - You have previously taken aromatase inhibitors - You have used prescription retinoids (tretinoin), Botox, fillers, facial lasers, or microneedling in the last 6 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNon-Interventional Study

Non-interventional study


Locations(1)

Mayo Clinic in Florida

Jacksonville, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06401889


Related Trials